๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Advanced Fallopian Tube Carcinoma

Study of AVZO-021 in Patients With Advanced Solid Tumors NCT05867251Phase 1, Phase 213 sites๐Ÿ“ New Haven๐Ÿ“ Sarasota๐Ÿ“ Tampa Avenzo Therapeutics, Inc. ยท Tests: AVZO-021, Palbociclib, Fulvestrant, Letrozole, Ribociclib A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003). NCT06843447Phase 1, Phase 239 sites๐Ÿ“ New Haven๐Ÿ“ Louisville๐Ÿ“ Shreveport Merck Sharp & Dohme LLC ยท Tests: Raludotatug Deruxtecan, Carboplatin, Paclitaxel, Bevacizumab, Rescue Medication Fluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian Cancer NCT06735326Phase 21 site๐Ÿ“ Jinan Qilu Hospital of Shandong University ยท Tests: Fluzoparib, Bevacizumab, Paclitaxel, Carboplatin Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers NCT06906341Phase 249 sites๐Ÿ“ Birmingham๐Ÿ“ Palo Alto๐Ÿ“ San Francisco Corcept Therapeutics ยท Tests: Relacorilant 150 mg once daily (QD), Nab-paclitaxel 80 mg/m^2, Bevacizumab 10 mg/kg A Study of PHST001 in Advanced Solid Tumors NCT06840886Phase 120 sites๐Ÿ“ Beverly Hills๐Ÿ“ Los Angeles๐Ÿ“ Palo Alto Pheast Therapeutics ยท Tests: PHST001, Paclitaxel, Topotecan, Doxorubicin, FOLFIRI Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer NCT05009082Phase 365 sites๐Ÿ“ Amberg๐Ÿ“ Augsburg๐Ÿ“ Bad Homburg AGO Study Group ยท Tests: Carboplatin, Paclitaxel, Bevacizumab, Niraparib Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer NCT05739981Phase 1, Phase 24 sites๐Ÿ“ Baltimore๐Ÿ“ New York๐Ÿ“ Oklahoma City Imunon ยท Tests: Paclitaxel, Carboplatin, Bevacizumab, IMNN-001 Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors NCT05985655Phase 1, Phase 215 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ New York Exscientia AI Ltd., a wholly owned subsidiary of Recursion โ€ฆ ยท Tests: GTAEXS617, SoC A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy NCT05460000Phase 250 sites๐Ÿ“ Innsbruck๐Ÿ“ Brussels๐Ÿ“ Ghent North Eastern German Society of Gynaecological Oncology ยท Tests: 3 cycles chemotherapy instead of 6 cycles chemotherapy, 6 cycles chemotherapy A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors NCT04657068Phase 1, Phase 288 sites๐Ÿ“ Birmingham๐Ÿ“ Scottsdale๐Ÿ“ Little Rock Artios Pharma Ltd ยท Tests: ART0380, Gemcitabine, Irinotecan CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer NCT07322094Phase 1, Phase 27 sites๐Ÿ“ Fullerton๐Ÿ“ Irvine๐Ÿ“ Los Angeles TORL Biotherapeutics, LLC ยท Tests: TORL-1-23 and paclitaxel, TORL-1-23 and carboplatin, TORL-1-23, paclitaxel, and carboplatin A Study of SYS6043 in Platinum-Resistant, Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancers NCT07708753Phase 31 site๐Ÿ“ Beijing CSPC Megalith Biopharmaceutical Co.,Ltd. ยท Tests: SYS6043, Liposomal doxorubicin, paclitaxel, or topotecan Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies NCT05417594Phase 1, Phase 232 sites๐Ÿ“ La Jolla๐Ÿ“ Los Angeles๐Ÿ“ San Francisco AstraZeneca ยท Tests: AZD9574, Temozolomide (TMZ), [11C]AZ1419 3391, Trastuzumab Deruxtecan (T-DXd), Datopotamab Deruxtecan (Dato-DXd) Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma NCT06969833NA1 site๐Ÿ“ Lille Centre Oscar Lambret ยท Tests: Constitution of a biological collection, Assessment of Quality of Life and level of anxiety/depression Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer NCT05200260Phase 29 sites๐Ÿ“ Foshan๐Ÿ“ Guangzhou๐Ÿ“ Hangzhou Shanghai Gynecologic Oncology Group ยท Tests: Primary debulking surgery, Neoadjuvant chemotherapy, PARP inhibitor, Bevacizumab A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRฮฑ)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer. NCT06890338Phase 273 sites๐Ÿ“ Birmingham๐Ÿ“ Mobile๐Ÿ“ Irvine AbbVie ยท Tests: Carboplatin, Mirvetuximab Soravtansine, Bevacizumab Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer NCT07851025Phase 3186 sites๐Ÿ“ Tampa๐Ÿ“ Baltimore๐Ÿ“ Billings AstraZeneca ยท Tests: Torvutatug samrotecan, Bevacizumab A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05) NCT07743164Phase 34 sites๐Ÿ“ Fountain Valley๐Ÿ“ Orlando๐Ÿ“ Tel Aviv Merck Sharp & Dohme LLC ยท Tests: R-DXd, Bevacizumab, Carboplatin, Paclitaxel, Gemcitabine CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. NCT06690775Phase 266 sites๐Ÿ“ Phoenix๐Ÿ“ Tucson๐Ÿ“ Duarte TORL Biotherapeutics, LLC ยท Tests: TORL-1-23, TORL-1-23, TORL-1-23, Pegfilgrastim (drug) Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) NCT05579366Phase 1, Phase 266 sites๐Ÿ“ Phoenix๐Ÿ“ Tucson๐Ÿ“ Los Angeles Genmab ยท Tests: Rina-S, Carboplatin, Bevacizumab, Pembrolizumab, Erythromycin Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer NCT04811703Phase 16 sites๐Ÿ“ Lille๐Ÿ“ Lille๐Ÿ“ Lyon Hospices Civils de Lyon ยท Tests: Combined PIPAC / IV chemotherapy treatment Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer NCT07022535Phase 21 site๐Ÿ“ Hong Kong The University of Hong Kong ยท Tests: KELIM, Carboplatin plus Paclitaxel, Interval debulking surgery A Study of Lorigerlimab in Participants With Advanced Solid Tumors NCT06730347Phase 216 sites๐Ÿ“ Los Angeles๐Ÿ“ New Orleans๐Ÿ“ Grand Rapids MacroGenics ยท Tests: Lorigerlimab A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine NCT06682988Phase 252 sites๐Ÿ“ Sarasota๐Ÿ“ Edgewood๐Ÿ“ Lexington AbbVie ยท Tests: Mirvetuximab Soravtansine A Study of Sovilnesib in Subjects With Ovarian Cancer NCT06084416Phase 111 sites๐Ÿ“ Birmingham๐Ÿ“ Little Rock๐Ÿ“ Newport Beach Volastra Therapeutics, Inc. ยท Tests: Sovilnesib REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors NCT06710548NA6 sites๐Ÿ“ Aurora๐Ÿ“ Boulder๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: REVITALIZE Intervention, Educational Materials Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer NCT05236686NA1 site๐Ÿ“ Shanghai Shanghai Gynecologic Oncology Group ยท Tests: Hepato-celiac lymphadenectomy Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax NCT05092373Phase 11 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Atezolizumab, Cabozantinib S-malate, Nab-paclitaxel, Tumor Treating Fields Therapy Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial NCT04575935Phase 319 sites๐Ÿ“ Miami๐Ÿ“ Weston๐Ÿ“ Boston M.D. Anderson Cancer Center ยท Tests: Chemotherapy, Laparotomy, Minimally Invasive Surgery, Quality-of-Life Assessment, Questionnaire Administration Folate Receptor Alpha Dendritic Cells (FRฮฑDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial NCT06639074Phase 23 sites๐Ÿ“ Scottsdale๐Ÿ“ Jacksonville๐Ÿ“ Rochester Mayo Clinic ยท Tests: Biopsy, Biospecimen Collection, Computed Tomography, Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorโ€ฆ
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy